TARA MABON: Open Payments
NPI 1619136306 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 23 payments from 10 companies in 2025. Trend: 2023 $87 · 2024 $563 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 8 | $477 |
| Exact Sciences Corporation | 4 | $159 |
| Novo Nordisk Inc | 1 | $117 |
| Biogen, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $42 |
| Dynavax Technologies Corporation | 2 | $39 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| Insulet Corporation | 1 | $21 |
Products named: DEXCOM G7 GSS (161), The Cologuard Plus Collection Kit, Dexcom G6 Transmitter, Ozempic, ZURZUVAE, Heplisav-B, TRELEGY ELLIPTA, ZEPBOUND.
Industry payments across TN — which companies pay providers there.
